ANUH PHARMA Financial Statement Analysis
|
||
The Revenues of ANUH PHARMA have increased by 8.39% YoY .
The Earnings Per Share (EPS) of ANUH PHARMA has increased by 18.36 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
ANUH PHARMA Last 5 Annual Financial Results
[BOM: 506260]
Standalone | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹527 Cr | ₹487 Cr | ₹432 Cr | ₹307 Cr | ₹321 Cr |
Expenses | ₹476 Cr | ₹439 Cr | ₹387 Cr | ₹284 Cr | ₹291 Cr |
Operating Profit (Excl OI) | ₹52 Cr | ₹47 Cr | ₹45 Cr | ₹23 Cr | ₹30 Cr |
Other Income | ₹6.12 Cr | ₹5.20 Cr | ₹11 Cr | ₹4.21 Cr | ₹4.70 Cr |
Interest | ₹0.75 Cr | ₹1.58 Cr | ₹2.03 Cr | ₹1.26 Cr | ₹0.60 Cr |
Depreciation | ₹9.70 Cr | ₹12 Cr | ₹15 Cr | ₹7.03 Cr | ₹1.66 Cr |
Profit Before Tax | ₹47 Cr | ₹39 Cr | ₹39 Cr | ₹19 Cr | ₹32 Cr |
Profit After Tax | ₹36 Cr | ₹31 Cr | ₹28 Cr | ₹14 Cr | ₹23 Cr |
Consolidated Net Profit | ₹36 Cr | ₹31 Cr | ₹28 Cr | ₹14 Cr | ₹23 Cr |
Earnings Per Share (Rs) | ₹7.22 | ₹6.10 | ₹5.67 | ₹5.71 | ₹9.33 |
PAT Margin (%) | 6.83 | 6.22 | 6.46 | 4.50 | 7.25 |
ROE(%) | 15.90 | 15.11 | 16.12 | 8.75 | 14.87 |
ROCE(%) | 21.05 | 19.33 | 19.75 | 10.87 | 20.56 |
Total Debt/Equity(x) | 0.00 | 0.01 | 0.07 | 0.27 | 0.03 |
Key Financials |
||
Market Cap | : | ₹ 1,182.6 Cr |
Revenue (TTM) | : | ₹ 640.4 Cr |
Net Profit(TTM) | : | ₹ 54.3 Cr |
EPS (TTM) | : | ₹ 10.8 |
P/E (TTM) | : | 21.8 |
Industry Peers & Returns | 1W | 1M | 1Y |
ANUH PHARMA | 13.4% | 9.1% | 201.6% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
ANUH PHARMA Revenues
[BOM: 506260]
Y-o-Y | 8.39 % |
5 Yr CAGR | 13.25 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹527 Cr | 8.39 | |
Mar2022 | ₹487 Cr | 12.66 | |
Mar2021 | ₹432 Cr | 40.72 | |
Mar2020 | ₹307 Cr | -4.27 | |
Mar2019 | ₹321 Cr | - |
ANUH PHARMA Operating Profit
[BOM: 506260]
Y-o-Y | 9.14 % |
5 Yr CAGR | 14.67 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹52 Cr | 9.14 | |
Mar2022 | ₹47 Cr | 5.20 | |
Mar2021 | ₹45 Cr | 94.19 | |
Mar2020 | ₹23 Cr | -22.45 | |
Mar2019 | ₹30 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 0.72 % |
5 Yr CAGR | 1.26 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 9.82% | 0.72 | |
Mar2022 | 9.75% | -6.70 | |
Mar2021 | 10.45% | 38.04 | |
Mar2020 | 7.57% | -18.95 | |
Mar2019 | 9.34% | - |
ANUH PHARMA Profit After Tax
[BOM: 506260]
Y-o-Y | 18.39 % |
5 Yr CAGR | 11.55 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹36 Cr | 18.39 | |
Mar2022 | ₹31 Cr | 7.47 | |
Mar2021 | ₹28 Cr | 98.78 | |
Mar2020 | ₹14 Cr | -38.78 | |
Mar2019 | ₹23 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 9.81 % |
5 Yr CAGR | -1.48 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 6.83 % | 9.81 | |
Mar2022 | 6.22 % | -3.72 | |
Mar2021 | 6.46 % | 43.56 | |
Mar2020 | 4.5 % | -37.93 | |
Mar2019 | 7.25 % | - |
ANUH PHARMA Earnings Per Share (EPS)
[BOM: 506260]
Y-o-Y | 18.36 % |
5 Yr CAGR | -6.21 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹7.22 | 18.36 | |
Mar2022 | ₹6.10 | 7.58 | |
Mar2021 | ₹5.67 | -0.70 | |
Mar2020 | ₹5.71 | -38.80 | |
Mar2019 | ₹9.33 | - |
ANUH PHARMA Return on Capital Employed (ROCE)
[BOM: 506260]
Y-o-Y | 8.90 % |
5 Yr CAGR | 0.59 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 21.05% | 8.90 | |
Mar2022 | 19.33% | -2.13 | |
Mar2021 | 19.75% | 81.69 | |
Mar2020 | 10.87% | -47.13 | |
Mar2019 | 20.56% | - |
ANUH PHARMA Share Price vs Sensex
Current Share Price | : | ₹236.1 |
Current MarketCap | : | ₹ 1,182.6 Cr |
Updated EOD on | : | Apr 24,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ANUH PHARMA | 13.4% |
9.1% |
201.6% |
SENSEX | 1.3% |
2.6% |
24% |
ANUH PHARMA related INDICES
You may also like the below Video Courses
FAQ about ANUH PHARMA Financials
How the annual revenues of ANUH PHARMA have changed ?
The Revenues of ANUH PHARMA have increased by 8.39% YoY .
How the Earnings per Share (EPS) of ANUH PHARMA have changed?
The Earnings Per Share (EPS) of ANUH PHARMA has increased by 18.36 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs